NCI National Clinical Trials Network (NCTN) Program Guidelines

More documents

Recommendations

Info

Part 4: Appendices – VII. NCTN Program Data & Safety Monitoring Policy for Phase 3 & Randomized Phase 2 Trials Table of Membership of DSMB/DMC and Attendance at Sessions If the DSMB/DMC has voting members who are also members of the Network Group, the majority of voting DSMB/DMC members cannot belong to the Network Group and voting quorums for a DSMB/DMC meeting require that the majority of voting members not belong to the Network Group. DSMB/DMC Membership Type Voting member of DSMB/DMC NCI/DCTD (non-voting) member of DSMB/DMC Study statistician Designated Network Group Statistician (non-voting) Designated Network Group Chair or any member of the executive leadership Open session Present Present Present Present Present (if he/she desires) Closed Session Present (except if member of the study team or leadership of the disease committee for the study under consideration) Present Present Present Absent Executive Session Present (except if member of the study team or leadership of the disease committee for the study under consideration) Present Absent Present (except if study statistician for the study under consideration, in which case, the Designated Network Group Statistician can name another statistician from the Network Group as his/her non-voting designee for the executive session) Absent Page 232 of 241
Part 4: Appendices – IX. Common Budget Outline IX. Common Budget Outline for Network Group Operations Center Applications – Suggested Format (Submitted in Network Group Ops Center Applications Only) Heading for All Costs (except for per case reimbursement) FTEs Salaries & Wages Fringe Consultants Equipment Supplies Travel INFRASTRUCTURE COSTS A. Group Leadership 1. Group Chair and Vice Chairs (include all Multiple PI(s)/PD(s) on grant application) Salary, fringe, travel and consortium/contractual indirect costs for Group Chair and any Vice or Deputy Chairs 2. Executive Medical Officers Salary, fringe, travel and consortium/contractual indirect costs for physicians who have oversight responsibilities for scientific activities SUBTOTAL - GROUP LEADERSHIP B. Scientific Leadership 1. Scientific Committee Leadership Salary, fringe, travel and consortium/contractual indirect costs for Chairs, Vice and Deputy Chairs, Subcommittee Chairs 2. Administrative Committee Leadership Salary, fringe, travel and consortium/contractual indirect costs for Chairs, Vice and Deputy Chairs, Subcommittee Chairs 3. Protocol Chairs Salary, fringe, travel and consortium/contractual indirect costs or fixed payments for protocol chairs SUBTOTAL - SCIENTIFIC LEADERSHIP C. Group Administration Consortium/ Contractual Alterations/ Renovations Other Indirect TOTAL 1. General Administration Salary, fringe, office costs, travel and consortium/contractual indirect costs for administrative management, Chair's Office, if applicable, and meeting support 2. Finance/Contracting Salary, fringe and consortium/contractual indirect costs for finance and contracting staff 3. IT Support Salary, fringe, consortium/contractual indirect costs or other costs for administration IT support 4. Rent Rental costs paid for Group space from direct dollars SUBTOTAL - GROUP ADMINISTRATION Page 233 of 241
Page 1 and 2:
NATIONAL CANCER INSTITUTE NATIONAL
Page 3 and 4:
NCTN Program Guidelines Table of Co
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
PART 1: Overview of NCTN Program Se
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
PART 1: Overview of the NCTN Progra
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
PART 2: Submission of Competing New
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
PART 2: Submission of New/Competing
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182: PART 2: Submission of New/Competing
Page 187 and 188: PART 3: Submission of Non-Competing
Page 189 and 190: TYPE OF STUDY PART 3: Submission No
Page 191 and 192: PART 3: Submission Non-Competing Ap
Page 193 and 194: PART 3: Submission Non-Competing Ap
Page 195 and 196: PART 4: Appendices Section II - Req
Page 201 and 202: Participating Site Member Category
Page 211 and 212: PART 4: Appendices Section IV - Cos
Page 217 and 218: PART 4: Appendices Section V - Impo
Page 223 and 224: Part 4: Appendices - VI. Sample Tab
Page 225 and 226: Part 4: Appendices - VII. Model for
Page 227 and 228: Part 4: Appendices - VII. NCTN Prog
Page 229 and 230: Part 4: Appendices - VII. NCTN Prog
Page 231: Part 4: Appendices - VII. NCTN Prog
Page 235 and 236: Part 4: Appendices - IX. Common Bud
Page 237 and 238: Part 4: Appendices - VII. Accrual I
Page 239 and 240: Part 4: Summary of Updates to Guide
Page 241: Part 4: Summary of Updates to Guide
show all

NCI National Clinical Trials Network (NCTN) Program Guidelines

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?